Summary of clinico-pathological and immunohistochemical data.

In cohort 2, the distribution of immunohistochemical H-scores (intensity of immunoreactivity multiplied by frequency of stained cells) is indicated for both pre-and post-chemotherapy (pre-CT/post-CT) biopsies and surgical specimens, respectively. amodified RECIST criteria were only available for 97 patients.
Summary of clinico-pathological and immunohistochemical data.

在队列2中，分别展示了化疗前（pre-CT）、化疗后（post-CT）活检组织与手术标本的免疫组化H评分（immunohistochemical H-scores）分布情况，该评分定义为免疫反应强度乘以染色细胞频率。仅97例患者可获得改良实体瘤疗效评价标准（modified RECIST criteria）的数据。临床病理及免疫组化数据汇总。